| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.0M | +77.6% |
| Cost of Revenue | $50.9M | +83.9% |
| Gross Profit | $19.1M | +62.7% |
| R&D Expense | $7.0M | +38.0% |
| SG&A Expense | $51.4M | +144.0% |
| Operating Income | -$39.3M | -173.2% |
| Net Income | -$37.5M | -116.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $18.2M | +72.5% |
| Inventory | $38.4M | +331.1% |
| Current Assets | $64.9M | +167.0% |
| Total Assets | $79.0M | +187.2% |
| Current Liabilities | $21.1M | +158.6% |
| Total Liabilities | $21.1M | +158.6% |
| Stockholders' Equity | $57.9M | +199.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$66.2M | -164.1% |
| Capital Expenditures | $11.3M | +352.4% |
| Investing Cash Flow | -$11.3M | -2350.9% |
| Financing Cash Flow | $82.8M | +209.6% |
| Free Cash Flow | -$77.5M | -181.1% |